Aurobindo’s North Carolina Plant Receives VAI Status, Clearing Path for US Product Approvals
Aurobindo Pharma's North Carolina facility receives Voluntary Action Indicated (VAI) status from the U.S. FDA, allowing pending product applications to advance. This regulatory clarity holds key lessons for Indian startups in regulated sectors.